JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 Bispecific Antibody, in Prostate Cancer: Initial Results from a Phase 1 Dose Escalation Study
JNJ-70218902
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 Bispecific Antibody, in Prostate Cancer: Initial Results from a Phase 1 Dose Escalation Study ### Output: JNJ-70218902